Tirzepatide

Tirzepatide (GIP/GLP-1 Dual Agonist)

Dual GIP and GLP-1 receptor agonist for advanced metabolic clinical use.

Purity

99.2%

Form

Lyophilized Powder

CAS Number

2023788-19-2

Storage

-20°C, protected from light

Overview

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its unique dual-agonist mechanism produces superior metabolic outcomes compared to single-agonist compounds. For use exclusively in licensed clinical metabolic protocols.

Research Applications

Advanced metabolic protocol management

Weight management and obesity treatment

Type 2 diabetes glycemic control

Dual incretin effect research

Cardiovascular outcome studies

Technical Specifications

Molecular FormulaC225H348N48O68

Molecular Weight4813.48 g/mol

CAS Number2023788-19-2

Sequence39-amino acid dual GIP/GLP-1 receptor agonist

AppearanceWhite lyophilized powder

ReconstitutionBacteriostatic water

Storage-20°C, protected from light

COA Available

Lot-specific Certificate of Analysis available upon request for all approved wholesale accounts. Includes HPLC and mass spectrometry data.

Request COA

Quality Standards

GMP-certified synthesis

Independent HPLC verification

Mass spectrometry confirmed

Lot-specific documentation

Wholesale Inquiry

Available to licensed medical providers only. Submit credentials to receive pricing and availability.

Request Access

Related Compounds — GLP-1 Receptor Agonists

Semaglutide

Semaglutide (GLP-1 Analog)

99.1%View

Retatrutide

Retatrutide (GIP/GLP-1/Glucagon Triple Agonist)

99.0%View

Cagrilintide + Semaglutide

Cagrilintide + Semaglutide Combination (CagriSema)

99.0%View